dc.contributor.author | Linton, MacRae F. | |
dc.contributor.author | Moslehi, Javid J. | |
dc.contributor.author | Babaev, Vladimir R. | |
dc.date.accessioned | 2020-04-24T19:57:29Z | |
dc.date.available | 2020-04-24T19:57:29Z | |
dc.date.issued | 2019-06-01 | |
dc.identifier.citation | Linton, M.F.; Moslehi, J.J.; Babaev, V.R. Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis. Int. J. Mol. Sci. 2019, 20, 2703. | en_US |
dc.identifier.issn | 1422-0067 | |
dc.identifier.uri | http://hdl.handle.net/1803/9953 | |
dc.description.abstract | The PI3K/Akt pathway plays a crucial role in the survival, proliferation, and migration of macrophages, which may impact the development of atherosclerosis. Changes in Akt isoforms or modulation of the Akt activity levels in macrophages significantly affect their polarization phenotype and consequently atherosclerosis in mice. Moreover, the activity levels of Akt signaling determine the viability of monocytes/macrophages and their resistance to pro-apoptotic stimuli in atherosclerotic lesions. Therefore, elimination of pro-apoptotic factors as well as factors that antagonize or suppress Akt signaling in macrophages increases cell viability, protecting them from apoptosis, and this markedly accelerates atherosclerosis in mice. In contrast, inhibition of Akt signaling by the ablation of Rictor in myeloid cells, which disrupts mTORC2 assembly, significantly decreases the viability and proliferation of blood monocytes and macrophages with the suppression of atherosclerosis. In addition, monocytes and macrophages exhibit a threshold effect for Akt protein levels in their ability to survive. Ablation of two Akt isoforms, preserving only a single Akt isoform in myeloid cells, markedly compromises monocyte and macrophage viability, inducing monocytopenia and diminishing early atherosclerosis. These recent advances in our understanding of Akt signaling in macrophages in atherosclerosis may have significant relevance in the burgeoning field of cardio-oncology, where PI3K/Akt inhibitors being tested in cancer patients can have significant cardiovascular and metabolic ramifications. | en_US |
dc.description.sponsorship | This work was supported by National Institutes of Health grants HL105375, HL116263, DK50435, DK59637 (Lipid, Lipoprotein, and Atherosclerosis Core of the Vanderbilt Mouse Metabolic Phenotype Centers). | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | International Journal of Moledular Sciences | en_US |
dc.rights | All articles published by MDPI are made immediately available worldwide under an open access license. This means:
everyone has free and unlimited access to the full-text of all articles published in MDPI journals;
everyone is free to re-use the published material if proper accreditation/citation of the original publication is given;
open access publication is supported by the authors' institutes or research funding agencies by payment of a comparatively low Article Processing Charge (APC) for accepted articles.
No special permission is required to reuse all or part of article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. Reuse of an article does not imply endorsement by the authors or MDPI. | |
dc.source.uri | https://www.mdpi.com/1422-0067/20/11/2703 | |
dc.subject | atherosclerosis | en_US |
dc.subject | macrophages | en_US |
dc.subject | Akt signaling | en_US |
dc.subject | polarization | en_US |
dc.subject | apoptosis | en_US |
dc.subject | survival | en_US |
dc.title | Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3390/ijms20112703 | |